Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma

This publication has 21 references indexed in Scilit:

• Syndecan-1: A New Prognostic Marker in Laryngeal Cancer
  Acta Oto-Laryngologica, 1997
• IMMUNOLOGIC DYSFUNCTION IN CANCER
  Hematology/Oncology Clinics of North America, 1996
• Correlation of Tumor Markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 With Survival and Metastasis in Laryngeal Squamous Cell Carcinoma
  JAMA Otolaryngology–Head & Neck Surgery, 1996
• The antimetabolite tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells
  European Journal Of Cancer, 1996
• Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
  The Journal of cell biology, 1995
• Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis
  Cancer and Metastasis Reviews, 1993
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
  Cell, 1991
• Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
  Cell, 1991
• The barrier-like role of activated connective tissue against the spread of supraglottic laryngeal carcinoma
  European Archives of Oto-Rhino-Laryngology, 1988
• Evidence for a Novel Gene Associated With Low Tumor Metastatic Potential
  JNCI Journal of the National Cancer Institute, 1988